Ropes & Gray advised Summa Equity AB, Olink Holding AB’s largest shareholder, in a sale to Thermo Fisher Scientific Inc. Olink products and services provide pharmaceutical companies and clinical and academic institutions with proteomics research across disease areas. Thermo Fisher will commence a tender offer to acquire all of the outstanding Olink common shares and all of the American Depositary Shares. The transaction, which values Olink at approximately $3.1 billion and includes net cash of approximately $143 million, was announced in a press release.
Summa Equity is a purpose-driven investment firm, investing across the themes of Resource Efficiency, Changing Demographics, and Tech-Enabled Transformation. Summa’s purpose is to co-create win-win for investors, portfolio companies, and society through aligning its vision and investing in line with the United Nation’s Sustainable Development Goals.
The Ropes & Gray team that represented Summa Equity was led by mergers & acquisition partner Suni Sreepada, executive compensation & employee benefits partners Renata Ferrari and Kyle Higley, tax partner Ben Rogers, capital markets & governance partner Chris Capuzzi and counsel Marc Rotter, asset management partner Yoni Levy and mergers & acquisitions associate Dan Sotsky.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.